Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in greater adverse effects such as drowsiness, although the clinical relevance is reduced in many sufferers – keep an eye on the client for adverse effects (e. If affected individual are unable to resume their normal https://medeusresearchchem.com/shop/